A few recent cancer research publications:

• New in the Journal of Clinical Oncology (JCO), is a report of National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer.
• In Blood, reports on clinical trails of Enasedenib in myeloid leukemia were published on August 10, Enasidenib in Mutant IDH2 Relapsed or Refractory Acute Myeloid Leukemia and,  Enasidenib Induces Acute Myeloid Leukemia Cell Differentiation to Promote Clinical Response.
• Researchers in Taiwan have published a review of Colorectal Cancer Screening in Asia.

Read on for some of the latest developments in cancer research.

• In a breakthrough study, scientist repaired a disease-causing mutation in human embryos:

U.S. scientists successfully gene-edit human… by tomonewsus

• Scientists at the University of Sheffield discovered that the drug methotrexate used for arthritis could be used to treat blood cancer patients. Initial tests were conducted on fruit fly cells. Further testing in human cells demonstrated the potential of methotrexate to directly inhibit the molecular pathway responsible for blood cancer.  Read more about these findings in Haematologica.
• The use of a contrast agent that makes tumors glow enabled surgeons to identify and remove a greater number of cancerous nodules. Researchers at the University of Pennsylvania used a near-infrared contrast agent called OTL3 when combining intraoperative molecular imaging with PET imaging.  For more, see study published in the Annals of Surgery.

The Latest in Cancer Research:

• Researchers have patented a mobile device that can detect tumor cells in the blood. The device appears to be very effective in monitoring, treating and diagnosing cancer. Read more on this development in Scientific Reports.
• According to lead researchers at Northwestern University, early studies have demonstrated a potential new therapy for treating glioblastoma that involves using lipid polymer based nanoparticles to deliver molecules to the tumors. For more, see Proceedings of the National Academy of Sciences.
• An international team led by scientists at the University of Montreal has identified a key new mechanism that regulates the ability of T-cells of the immune system to react against foreign antigens and cancer. Read more on this discovery in Nature Communications.
• The National Cancer Institute Genomic Data Commons has officially launched DAVE: Data Analysis, Visualization, and Exploration. DAVE will allow users to interact with data and promote the cancer genomics knowledge base. See DAVE tools for more.